0001225208-20-003805.txt : 20200228
0001225208-20-003805.hdr.sgml : 20200228
20200228193436
ACCESSION NUMBER: 0001225208-20-003805
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200226
FILED AS OF DATE: 20200228
DATE AS OF CHANGE: 20200228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MACKENZIE ALEXANDER R
CENTRAL INDEX KEY: 0001678459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 20673644
MAIL ADDRESS:
STREET 1: C/O PFIZER CORP. SECRETARY
STREET 2: 235 EAST 42ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0306
4
2020-02-26
0000078003
PFIZER INC
PFE
0001678459
MACKENZIE ALEXANDER R
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK
NY
10017
1
Executive Vice President
Common Stock
2020-02-26
4
A
0
21202.0000
0.0000
A
101323.0000
D
Common Stock
2020-02-26
4
A
0
17087.0000
0.0000
A
118410.0000
D
Common Stock
2020-02-26
4
F
0
7984.0000
34.7200
D
110426.0000
D
Common Stock
2020-02-26
4
F
0
8104.0000
34.7200
D
102322.0000
D
Common Stock
9702.0000
I
By Rule 16b-3 Plan
Stock Appreciation Rights
34.1000
2020-02-27
4
A
0
102221.0000
0.0000
A
2025-02-27
2025-02-27
Common Stock
102221.0000
102221.0000
D
Stock Appreciation Rights
34.1000
2020-02-27
4
A
0
87581.0000
0.0000
A
2027-02-27
2027-02-27
Common Stock
87581.0000
87581.0000
D
The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
Susan E. Grant, by power of atty., for Alexander R. MacKenzie
2020-02-28